Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.09B |
| 2 |
Apple
AAPL
|
+$871M |
| 3 |
Uber
UBER
|
+$867M |
| 4 |
NVIDIA
NVDA
|
+$687M |
| 5 |
Amazon
AMZN
|
+$649M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATVI
Activision Blizzard
ATVI
|
+$1.52B |
| 2 |
Danaher
DHR
|
+$540M |
| 3 |
VMW
VMware, Inc
VMW
|
+$474M |
| 4 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$450M |
| 5 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$388M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.83% |
| 2 | Financials | 12.77% |
| 3 | Healthcare | 12.47% |
| 4 | Consumer Discretionary | 11% |
| 5 | Industrials | 9.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AKRO
1726
DELISTED
Akero Therapeutics
AKRO
| $27.2M | ﹤0.01% |
1,166,245
+62,939
| +6% | +$1.24M |
|
1727
Madison Square Garden
MSGE
$3.7B
| $27.2M | ﹤0.01% |
855,062
+3,809
| +0.4% | +$118K |
|
|
RYZB
1728
DELISTED
RayzeBio, Inc. Common Stock
RYZB
| $27M | ﹤0.01% |
434,891
+390,406
| +878% | +$9.7M |
|
|
SCS
1729
DELISTED
Steelcase
SCS
| $26.9M | ﹤0.01% |
1,988,762
+87,285
| +5% | +$1.04M |
|
1730
Malibu Boats
MBUU
$556M
| $26.9M | ﹤0.01% |
490,289
+16,664
| +4% | +$799K |
|
|
PRMW
1731
DELISTED
Primo Water Corporation
PRMW
| $26.9M | ﹤0.01% |
1,785,255
+84,952
| +5% | +$1.21M |
|
1732
Zeta Global
ZETA
$5.59B
| $26.8M | ﹤0.01% |
3,041,961
+169,931
| +6% | +$1.43M |
|
|
SASR
1733
DELISTED
Sandy Spring Bancorp Inc
SASR
| $26.8M | ﹤0.01% |
982,643
+47,357
| +5% | +$1.07M |
|
1734
Sprinklr
CXM
$1.54B
| $26.8M | ﹤0.01% |
2,222,979
+161,515
| +8% | +$2.22M |
|
|
BBBY
1735
Bed Bath & Beyond
BBBY
$500M
| $26.7M | ﹤0.01% |
1,061,623
+7,075
| +0.7% | +$122K |
|
1736
Reynolds Consumer Products
REYN
$5.33B
| $26.7M | ﹤0.01% |
993,687
+32,446
| +3% | +$847K |
|
1737
UFP Technologies
UFPT
$2.04B
| $26.6M | ﹤0.01% |
154,867
+7,562
| +5% | +$1.22M |
|
1738
Compass
COMP
$8.81B
| $26.6M | ﹤0.01% |
7,081,291
+311,801
| +5% | +$770K |
|
|
AAT
1739
American Assets Trust
AAT
$1.46B
| $26.6M | ﹤0.01% |
1,181,557
+37,803
| +3% | +$749K |
|
1740
John Wiley & Sons Class A
WLY
$2.7B
| $26.5M | ﹤0.01% |
835,620
-39,280
| -4% | -$1.23M |
|
1741
Ligand Pharmaceuticals
LGND
$5.76B
| $26.5M | ﹤0.01% |
370,815
+18,194
| +5% | +$1.07M |
|
1742
Magnite
MGNI
$2.81B
| $26.4M | ﹤0.01% |
2,830,547
+157,566
| +6% | +$1.24M |
|
1743
Kinross Gold
KGC
$27.3B
| $26.4M | ﹤0.01% |
4,401,012
+156,198
| +4% | +$854K |
|
1744
Seadrill
SDRL
$2.69B
| $26.4M | ﹤0.01% |
558,181
+27,543
| +5% | +$1.17M |
|
1745
Legend Biotech
LEGN
$3.66B
| $26.4M | ﹤0.01% |
440,875
+79,673
| +22% | +$5.05M |
|
1746
Encore Capital Group
ECPG
$2.08B
| $26.3M | ﹤0.01% |
518,809
+23,667
| +5% | +$1.07M |
|
1747
XPEL
XPEL
$1.23B
| $26.3M | ﹤0.01% |
487,654
+22,810
| +5% | +$1.23M |
|
1748
OneSpaWorld
OSW
$2.65B
| $26.2M | ﹤0.01% |
1,860,348
+101,970
| +6% | +$1.19M |
|
1749
Winmark
WINA
$1.24B
| $26.1M | ﹤0.01% |
62,563
+2,703
| +5% | +$1.14M |
|
|
INBX
1750
DELISTED
Inhibrx, Inc. Common Stock
INBX
| $26.1M | ﹤0.01% |
687,360
+41,201
| +6% | +$883K |
|
Similar funds
Geode Capital Management's Q4 2023 Portfolio in Review
As of Q4 2023, Geode Capital Management held 4,831 positions worth $956B, up 14% from $840B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Geode Capital Management's Q4 2023 filing shows 71 new, 3,576 increased, 304 reduced and 178 closed positions. Its largest new stake was NCR Atleos: 993,462 shares worth $24.2M. The largest sale was Activision Blizzard, an estimated $1.52B.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 28% a quarter earlier, followed by Financials and Healthcare.
- Geode Capital Management's largest Q4 2023 buy was NCR Atleos: 993,462 shares worth $24.2M.
- Geode Capital Management added most to Microsoft in Q4 2023, an estimated $1.09B increase.
- Geode Capital Management's biggest Q4 2023 reduction was Danaher, cutting an estimated $540M.
- Geode Capital Management fully exited Activision Blizzard in Q4 2023, selling an estimated $1.52B.
- Geode Capital Management's ten largest holdings make up 26% of its $956B portfolio in Q4 2023.
- Geode Capital Management opened 71 new positions and closed 178 in Q4 2023.
- Geode Capital Management's portfolio value rose 14% quarter-over-quarter to $956B.
Based on Geode Capital Management's 13F filing for Q4 2023, filed 13 Feb 2024.